Literature DB >> 1699166

Retrograde axonal transport of neurotensin in the dopaminergic nigrostriatal pathway in the rat.

M N Castel1, C Malgouris, J C Blanchard, P M Laduron.   

Abstract

Although the existence of receptor transport has been clearly demonstrated in peripheral nerves, there is no clear cut evidence in the brain of such a process for neuropeptide receptors. Because of the localization of neurotensin receptors on dopaminergic terminals, the dopaminergic nigrostriatal pathway appears to be the system of choice for studying the axonal transport of neuropeptide receptors in the brain. When labelled neurotensin was injected into the rat striatum, a delayed accumulation of radioactivity in the ipsilateral substantia nigra was observed about 2 h after injection. An essential requirement to clearly observe this phenomenon was the pretreatment of animals with kelatorphan in order to prevent the labelled neurotensin degradation. The appearance of this labelling was prevented by injection of an excess of unlabelled neurotensin or of neurotensin 8-13, an active neurotensin fragment, but not by neurotensin 1-8, which had no affinity for neurotensin receptors. This process was saturable, microtubule-dependent and occurred only in mesostriatal and nigrostriatal dopaminergic neurons as identified after 6-hydroxydopamine lesion and by autoradiography. These results demonstrate that neurotensin was retrogradely transported by a process involving neurotensin receptors. The retrograde transport of receptor-bound neuropeptide may represent an important dynamic process which conveys information molecules from the synapse towards the cell body.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699166     DOI: 10.1016/0306-4522(90)90438-a

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Detection of naturally expressed receptors for gastrin-releasing peptide and tachykinins using cyanine 3-labelled neuropeptides.

Authors:  N W Bunnett; D G Payan; E F Grady
Journal:  Histochem J       Date:  1996-11

2.  Neurotensin Release from Dopamine Neurons Drives Long-Term Depression of Substantia Nigra Dopamine Signaling.

Authors:  Christopher W Tschumi; Harris E Blankenship; Ramaswamy Sharma; William B Lynch; Michael J Beckstead
Journal:  J Neurosci       Date:  2022-07-06       Impact factor: 6.709

3.  Treatment of PC12 cells by nerve growth factor, dexamethasone, and forskolin. Effects on cell morphology and expression of neurotensin and tyrosine hydroxylase.

Authors:  T Caillaud; W Y Opstal; V Scarceriaux; C Billardon; W Rostene
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

4.  Identification of Neurotensin Receptor Expressing Cells in the Ventral Tegmental Area across the Lifespan.

Authors:  Hillary L Woodworth; Patricia A Perez-Bonilla; Bethany G Beekly; Trevor J Lewis; Gina M Leinninger
Journal:  eNeuro       Date:  2018-02-12

Review 5.  Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System.

Authors:  Ana P Spencer; Marília Torrado; Beatriz Custódio; Sara C Silva-Reis; Sofia D Santos; Victoria Leiro; Ana P Pêgo
Journal:  Pharmaceutics       Date:  2020-02-23       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.